Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)

Pim Hendriks*, Daphne D.D. Rietbergen, Arian R. van Erkel, Minneke J. Coenraad, Mark J. Arntz, Roel J. Bennink, Andries E. Braat, Lioe Fee de Geus-Oei, Mark C. Burgmans, More Authors

*Corresponding author for this work

Research output: Contribution to journal › Article › Scientific › peer-review

10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)'. Together they form a unique fingerprint.

INIS

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry